Affinity Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331K Hold
360
0.21% 107
2025
Q4
$387K Hold
360
0.26% 95
2025
Q3
$275K Hold
360
0.19% 112
2025
Q2
$281K Hold
360
0.21% 111
2025
Q1
$297K Hold
360
0.24% 110
2024
Q4
$278K Hold
360
0.23% 109
2024
Q3
$319K Buy
+360
New +$324K 0.22% 109

Other funds holding LLY

Affinity Investment Advisors's LLY Position: Q1 2026 in Review

Affinity Investment Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 360 shares worth $331K. The position accounts for 0.21% of the portfolio, ranked #107.

Affinity Investment Advisors first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $387K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Affinity Investment Advisors held 360 shares of Eli Lilly worth $331K as of Q1 2026.
  • Affinity Investment Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.21% of Affinity Investment Advisors's portfolio in Q1 2026, its #107 holding.
  • Affinity Investment Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Affinity Investment Advisors's Eli Lilly position peaked at $387K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Affinity Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.